One health
Communicable diseases remain one of the major causes of mortality worldwide. There are disparities in the numbers of individuals affected by disease between low-and-middle-income countries and those in developed nations. Microbes will play in important role in drug discovery: producing anticancer drugs and antimicrobials. Applying One Health principles, to understand the interaction of pathogens and the human host, development of diagnostics, treatments, and disease prevention, applied microbiologists can shape global health and wellbeing outcomes.
News
Association between gene variants and COVID-19 susceptibility and severity in Jordanians
A new study identifies single-nucleotide polymorphisms in the TMPRSS2 gene as promising genetic biomarkers to stratify Jordanian individuals at high risk of COVID-19 infection.
Read story
NewsYeast‑derived universal flu vaccine could someday replace yearly injections
Engineered baker’s yeast produces virus-like particles that protect mice against multiple influenza strains.
NewsNew study maps how gut bacteria help and hinder each other’s growth
Researchers have now systematically mapped interactions between common gut bacteria, revealing both competitive and cooperative mechanisms and creating one of the most comprehensive datasets of its kind.
NewsIdentification and characterization of anti-chikungunya virus compounds using a biosafe toolkit
A new study characterizes several novel anti-chikungunya virus compounds and highlights the potential of combining screening approaches with mechanistic analyses to explore new antiviral strategies against emerging viral pathogens.
More One Health
News
Changes to California’s landscapes may influence Valley fever risk
A new study links higher disease rates to certain agricultural and natural landscapes near California communities, raising concerns as drought and water regulations lead to more farmland being left uncultivated across the state.
NewsPotential of antibody therapy in treating tick-borne diseases
A new study identifies multiple targets for antibodies that could open new paths toward treatments for Crimean-Congo hemorrhagic fever.
NewsUNC Study shows lyme disease is firmly established in western North Carolina
Community-led research in Buncombe County reveals 40% of blacklegged ticks in western North Carolina carry the bacteria that causes Lyme Disease.
NewsResearchers identify the immune cells that keep a deadly fungus in check
A new study finds that control of Cryptococcus neoformans depends not on a single immune cell type, but on several working together — a discovery that could reshape how doctors think about preventing life-threatening fungal infections.
NewsDelayed antiviral immune responses in alveolar cells increases susceptibility to influenza virus
A new study finds alveolar type 2 cells mount slower interferon-driven antiviral defenses than type 1 cells, enabling higher viral replication during influenza infection.
NewsHow the Chagas disease parasite ‘activates’ its form capable of infecting mammals
A new study helps determine how Trypanosoma cruzi manipulates its own RNA to alter protein production and invade the host, which could lead to new therapeutic approaches against Chagas disease.
NewsDaily dose of zinc reduces infections by nearly 40% in children with sickle cell anemia
A new study shows that a daily 20mg dose of zinc reduced infections by nearly 40% among Ugandan children younger than 5 with sickle cell anemia.
NewsWorld Mosquito Day 2026: the essential role of mosquito control in tackling increases in mosquito-borne diseases in Europe
EU scientists urge that continued research into interventions and cross-sectoral collaboration is needed to develop effective mosquito control strategies, to help address the increase in mosquito-borne diseases in Europe.
NewsWhy immune responses to vaccines vary from person to person
A new study finds that past immune encounters may predict future vaccine response.
NewsMouth and gut microbes could help detect gastrointestinal cancers
Researchers report that by analyzing the make-up of oral microbes it may be possible to detect signals associated with stomach and colorectal cancer. These findings could lead to the development of new, less-invasive screening tests for gastrointestinal cancers.
NewsAntibiotic resistance is an environmental problem, not just a medical one
New research shows that wild farm mice carry around 50% of the antibiotic resistance genes found in livestock.
NewsInfluenza A infection under-reported during 2021 UK pandemic, researchers reveal
Influenza A infections were under-reported during the 2021 UK pandemic, according to research presented earlier this year at MLSFF 2026.
NewsGut bacteria convert dietary nitrate and iron into protective molecules
Researchers have discovered that gut bacteria can convert dietary nitrate and iron into protective molecules that may reduce the risk of cardiovascular and metabolic diseases.
NewsBacteria found in lung tumors may boost immune response to cancer
New preclinical study shows bacteria in lung tumors may boost the activation of innate immune cells in the presence of a common vitamin metabolite.
NewsCommon virus rewires energy metabolism in human neurons
Advanced optical imaging techniques reveal viral infection reshapes neuron metabolism long before major cell damage appears.
NewsA viral ‘loose cannon’ enzyme helps phages shut down bacterial defenses
Scientists have found how phages, viruses that infect bacteria, orchestrate an explosion of protein modifications inside host cells that helps them evade the bacteria’s immune systems.
NewsBladder infection after brain injury worsens cognitive problems
New research shows urinary tract infections following a moderate brain injury can worsen cognitive problems caused by the injury.
NewsFirst 24 hours after viral infection are critical
New research suggests that the first 24 hours after viral infection is critical in determining infection severity.
NewsNew discovery could help scientists fight deadly fungal infections
Researchers have discovered that the bacterial antibiotic ‘gladiolin’ can disarm Candida albicans, one of the leading causes of life-threatening fungal infections, opening new avenues for developing life-saving treatments.